Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| XOMA | XOMA ROYALTY CORP | $312.30M | 12,383,103 | 18.93% | 81.07% | Net Selling | Net Buying | ||
| AKA | AKA BRANDS HOLDING CORP | $126.08M | 10,739,676 | 4.11% | 95.89% | Net Selling | Net Selling | ||
| DMAC | DIAMEDICA THERAPEUTICS INC | $489.01M | 52,077,439 | 24.49% | 71.40% | Net Buying | Net Buying | ||
| NTGR | NETGEAR INC | $697.86M | 28,402,755 | 88.10% | 11.90% | Net Selling | Net Selling | ||
| CHYM | CHIME FINANCIAL INC | $9.81B | 374,577,986 | 56.25% | 26.72% | Net Selling | Net Selling | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $425.15M | 28,862,601 | 57.21% | 42.79% | Net Buying | Net Selling | ||
| CGTX | COGNITION THERAPEUTICS INC | $149.18M | 88,274,258 | 24.09% | 29.21% | Net Selling | Net Buying | ||
| OTLY | OATLY GROUP AB | $351.07M | 606,332,281 | 0.54% | 0.00% | ||||
| CRVO | CERVOMED INC | $78.19M | 9,252,719 | 2.96% | 97.04% | Net Buying | Net Buying | ||
| RZLT | REZOLUTE INC | $166.91M | 92,727,532 | 44.67% | 55.33% | Net Buying | |||
| BSVN | BANK7 CORP | $416.80M | 9,453,390 | 12.30% | 87.70% | Net Selling | Net Selling | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.45B | 71,949,027 | 75.16% | 24.84% | Net Buying | Net Buying | ||
| PHR | PHREESIA INC | $979.66M | 60,287,003 | 78.77% | 21.23% | Net Selling | Net Selling | ||
| SMWB | SIMILARWEB LTD | $645.40M | 86,283,483 | 52.99% | 0.00% | ||||
| CYBN | CYBIN INC | $153.86M | 23,033,127 | 39.83% | 0.00% | ||||
| ICHR | ICHOR HOLDINGS LTD | $612.73M | 34,384,231 | 68.63% | 31.37% | Net Buying | Net Buying | ||
| PRQR | PROQR THERAPEUTICS NV | $250.97M | 107,710,916 | 34.86% | 0.00% | ||||
| TBPH | THERAVANCE BIOPHARMA INC | $920.72M | 50,672,431 | 52.91% | 47.09% | Net Selling | Net Selling | ||
| SGMT | SAGIMET BIOSCIENCES INC | $202.61M | 32,521,599 | 36.57% | 63.43% | Net Selling | Net Selling | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.00B | 59,347,317 | 49.50% | 50.50% | Net Selling | Net Selling | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $339.39M | 29,182,511 | 59.89% | 9.25% | ||||
| XNCR | XENCOR INC | $1.18B | 71,410,469 | 72.07% | 27.93% | Net Selling | |||
| PSN | PARSONS CORP | $6.74B | 106,488,582 | 98.77% | 1.23% | Net Selling | |||
| ATR | APTARGROUP INC | $7.97B | 65,619,154 | 92.09% | 3.79% | Net Selling | |||
| SYRE | SPYRE THERAPEUTICS INC | $2.61B | 77,592,130 | 71.39% | 28.61% | Net Selling | Net Selling | ||
| ORIC | ORIC PHARMACEUTICALS INC | $913.51M | 97,389,279 | 83.32% | 16.68% | Net Selling | Net Selling | ||
| FBRX | FORTE BIOSCIENCES INC | $267.70M | 12,526,935 | 62.69% | 37.31% | Net Selling | Net Selling | ||
| PVLA | PALVELLA THERAPEUTICS INC | $1.17B | 11,836,490 | 57.88% | 42.12% | Net Buying | Net Buying | ||
| RIOT | RIOT PLATFORMS INC | $5.69B | 371,807,186 | 69.61% | 14.18% | Net Selling | Net Selling | ||
| IBIO | IBIO INC | $43.63M | 22,487,308 | 9.37% | 90.63% | Net Buying | |||
| TNGX | TANGO THERAPEUTICS INC | $1.26B | 134,593,998 | 62.83% | 37.17% | Net Selling | Net Selling | ||
| TVRD | TVARDI THERAPEUTICS INC | $41.37M | 9,381,344 | 7.84% | 92.16% | Net Selling | |||
| IDYA | IDEAYA BIOSCIENCES INC | $2.98B | 87,666,408 | 92.57% | 7.43% | Net Buying | |||
| BITF | BITFARMS LTD | $1.54B | 563,007,747 | 31.30% | 0.00% | ||||
| NAVN | NAVAN INC | N/A | 248,241,915 | 0.00% | 100.00% | Net Buying | Net Buying | ||
| CCCC | C4 THERAPEUTICS INC | $239.38M | 96,914,418 | 54.21% | 18.64% | Net Selling | Net Buying | ||
| TYRA | TYRA BIOSCIENCES INC | $1.21B | 53,372,098 | 62.03% | 37.97% | Net Buying | Net Selling | ||
| BLLN | BILLIONTOONE INC | $4.67B | 45,768,760 | 0.04% | 25.66% | Net Buying | Net Buying | ||
| OCUL | OCULAR THERAPEUTIX INC | $3.10B | 213,047,472 | 83.72% | 16.28% | Net Selling | Net Selling | ||
| CLFD | CLEARFIELD INC | $410.19M | 13,839,096 | 61.23% | 38.77% | Net Selling | Net Selling | ||
| TRVI | TREVI THERAPEUTICS INC | $1.64B | 128,230,134 | 41.41% | 58.59% | Net Buying | Net Buying | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $198.73M | 59,500,000 | 60.11% | 0.00% | ||||
| IMTX | IMMATICS NV | $1.22B | 121,563,829 | 76.04% | 0.00% | ||||
| CARL | CARLSMED INC | $344.38M | 26,592,908 | 17.53% | 54.30% | Net Buying | |||
| TIGR | UP FINTECH HOLDING LTD | $1.64B | 2,656,878,202 | 2.70% | 0.00% | ||||
| SLDB | SOLID BIOSCIENCES INC | $457.33M | 77,910,239 | 55.43% | 44.57% | Net Buying | Net Selling | ||
| OMDA | OMADA HEALTH INC | $874.41M | 57,908,047 | 54.33% | 3.95% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $704.19M | 59,076,259 | 55.51% | 44.49% | Net Buying | Net Buying | ||
| ALEC | ALECTOR INC | $162.64M | 109,151,472 | 61.20% | 38.80% | Net Selling | Net Selling | ||
| CMPX | COMPASS THERAPEUTICS INC | $917.77M | 177,862,102 | 78.76% | 21.24% | Net Selling | Net Selling | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $198.48M | 74,337,990 | 26.50% | 73.50% | Net Buying | Net Buying | ||
| VTYX | VENTYX BIOSCIENCES INC | $584.43M | 71,358,638 | 40.58% | 59.42% | Net Buying | Net Buying | ||
| AIRG | AIRGAIN INC | $48.43M | 11,958,193 | 31.95% | 30.36% | Net Buying | Net Selling | ||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1.32B | 82,787,220 | 25.49% | 74.51% | Net Selling | Net Selling | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $2.27B | 68,659,923 | 72.63% | 27.37% | Net Buying | Net Buying | ||
| LXEO | LEXEO THERAPEUTICS INC | $713.09M | 72,987,327 | 67.63% | 9.87% | Net Selling | Net Selling | ||
| T | AT&T INC | $174.26B | 7,089,449,495 | 64.42% | 0.31% | Net Selling | Net Selling | ||
| NRIX | NURIX THERAPEUTICS INC | $1.47B | 76,883,436 | 90.92% | 9.08% | Net Selling | Net Selling | ||
| NTSK | NETSKOPE INC | $8.15B | 393,258,861 | 35.83% | 11.95% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.